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Objective: To investigate perinatal outcomes according to the 2009 Institute of Medicine (IOM) gesta-
tional weight gain (GWG) guidelines.
Materials and methods: A retrospective cohort study was conducted among all term, singleton, live births
to women who delivered at the Taipei Chang Gung Memorial Hospital, Taipei, Taiwan between 2009 and
2014. Women were categorized into three groups based on prepregnancy body mass index and GWG
relative to the IOM guidelines. Multivariable logistic regression analysis was used to assess the associ-
ations between GWG outside the IOM guidelines and adverse perinatal outcomes. Women with GWG
within the guidelines served as the reference group.
Results: Of 9301 pregnancies, 2574 (27.7%), 4189 (45.0%), and 2538 (27.3%) women had GWG below,
within, and above the IOM guidelines. Women with GWG above the IOM guidelines were at risk for
preeclampsia [adjusted odds ratio (OR) 3.0, 95% conﬁdence interval (CI) 1.9e4.7], primary cesarean
delivery (adjusted OR 1.4, 95% CI 1.2e1.6) due to dysfunctional labor and cephalopelvic disproportion,
large-for-gestational age (adjusted OR 1.8, 95% CI 1.5e2.1), and macrosomic neonates (adjusted OR 2.2,
95% CI 1.6e3.1). Women with GWG below the IOM guidelines were more likely to be diagnosed with
gestational diabetes mellitus (adjusted OR 1.5, 95% CI 1.3e1.8) and were at higher risk for placental
abruption (adjusted OR 1.7, 95% CI 1.1e2.5), small-for-gestational age (adjusted OR 1.6, 95% CI 1.4e1.9),
and low birth weight neonates (adjusted OR 1.9, 95% CI 1.4e2.4).
Conclusion: Women with GWG outside the 2009 IOM guidelines were at risk for adverse maternal and
neonatal outcomes.
Copyright © 2015, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All
rights reserved.Introduction
In 2009, the Institute of Medicine (IOM) published revised
guidelines for weight gain during pregnancy [1]. Key changes made
from the previous 1990 IOM recommendations include: (1) the
adoption of the body mass index (BMI) categories developed by the
International Obesity Task Force and endorsed by the World Health
Organization, thus providing a consistent and universal message to
both women and health care providers about weight status; (2) and Gynecology, Taipei Chang
aipei 105, Taiwan.
bstetrics & Gynecology. Publishedchange in the cut-off points for the prepregnancy BMI category,
resulting in a smaller proportionofwomenclassiﬁedas underweight
and a larger proportion classiﬁed as overweight; and (3) a speciﬁc
and relatively narrow range of weight gain recommended for obese
women instead of a lower limit. The recommendation is for under-
weight, normal weight, overweight, and obese women to gain
12.5e18kg,11.5e16 kg, 7e11.5 kg, and5e9kg, respectively. The 2009
IOM weight gain guidelines were subsequently endorsed by the
Ministry of Health and Welfare, Taiwan, and are incorporated into
the Maternal Health Booklet for every pregnant woman in Taiwan.
Nevertheless, there have been only a few studies examining
maternal and neonatal outcomes in relation to the 2009 IOM
guidelines [2e11]. Most of these studies were performed on the
American or European populations [2,6e11] and have mainlyby Elsevier Taiwan LLC. All rights reserved.
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weight [4e8]. Data on whether adherence to the guidelines is
associated with improved maternal and neonatal outcomes in
Taiwanese women remain scarce. Therefore, we conducted a
retrospective cohort study to investigate the associations between
adverse perinatal outcomes and gestational weight gain (GWG)
above or below the 2009 IOM guidelines.
Materials and methods
A retrospective cohort study was conducted among all term,
singleton, live births to women who delivered at the Taipei Chang
Gung Memorial Hospital, Taipei, Taiwan between 2009 and 2014.
The study data were obtained from a computerized obstetrics
database, which included demographic characteristics, medical and
obstetric histories, and information regarding the course of the
index pregnancy and perinatal outcomes. The data in this database
were collected by trained personnel through daily abstraction from
the medical and delivery records and via postpartum interviews, if
necessary, to collect supplemental information. Audits of these data
were routinely performed every 2 weeks at the departmental
meetings. The study was approved by the Institutional Review
Board of Chang Gung Memorial Hospital.
We analyzed all deliveries after 37 0/7 weeks of gestation
(n ¼ 9972), excluding pregnancies complicated by multiple gesta-
tions (n ¼ 466), fetal chromosomal or structural anomalies
(n ¼ 101), and fetal demise (n ¼ 46). Women with chronic hyper-
tension (n ¼ 28) and prepregnancy diabetes mellitus (n ¼ 30) were
also excluded. Overall, a total of 9301 deliveries were selected for
the present analysis. Figure 1 depicts the sample selection process.Figure 1. Diagram of patient selection. GWG ¼ gestaIn this hospital, all pregnant women were measured for the
height and self-reported prepregnancy weight was recorded at
their ﬁrst antenatal visit. Height and self-reported prepregnancy
weight were used to calculate the prepregnancy BMI [calculated as
weight (kg)/height (m)2], which was further categorized into four
groups: underweight (<18.5 kg/m2), normal weight (18.5e24.9 kg/
m2), overweight (25.0e29.9 kg/m2), and obese (30.0 kg/m2).
GWG was calculated by subtracting each individual woman's
prepregnancy weight from her weight at delivery. Women were
categorized into three groups based on prepregnancy BMI and
GWG relative to the IOM guidelines: (1) weight gain below, (2)
weight within, and (3) weight gain above the IOM guidelines.
Perinatal outcomes were compared between the three groups
of women, using GWG within the IOM guidelines as the reference
group. We examined the following maternal outcomes: gesta-
tional diabetes mellitus (GDM), preeclampsia, premature rupture
of membranes, acute chorioamnionitis, induction of labor,
placental abruption, placenta accreta, postpartum hemorrhage
(>500 mL for vaginal delivery and >1000 mL for cesarean de-
livery), operative vaginal delivery, severe perineal injury (3rd and
4th degree perineal injury), and primary cesarean delivery (deﬁned
as a cesarean delivery performed for the ﬁrst time on a pregnant
woman). Neonatal outcomes examined were low birth weight
(<2500 g), small-for-gestational age (SGA, deﬁned as a birth
weight below the 10th percentile for the mean weight corrected
for fetal sex and gestational age), large-for-gestational age (LGA,
deﬁned as a birth weight above the 90th percentile for the mean
weight corrected for fetal sex and gestational age), macrosomia
(>4000 g), 1-minute and 5-minute Apgar score < 7, and neonatal
intensive care unit admission.tional weight gain; IOM ¼ Institute of Medicine.
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version 20.0 (SPSS Inc., Armonk, NY, USA). The categorical variables
were calculated as n (%) and were compared between the groups
using the c2 test. A p value < 0.05 was considered to be statistically
signiﬁcant. Multivariable logistic regression analysis was used to
control for potential confounding when assessing the associations
between adverse perinatal outcomes and GWG above or below the
IOM guidelines. Adjusted odds ratios (OR) and 95% conﬁdence in-
tervals (CI) were calculated to describe the relative risk.
Results
Of the 9301 women analyzed in this study, 1312 (14.1%) were
underweight, 6995 (72.0%) were of normal weight, 828 (8.9%)
were overweight, and 166 (1.8%) were obese based on their pre-
pregnancy BMI category. Of these women, 2574 (27.7%) women
had GWG below, 4189 (45.0%) within, and 2538 (27.3%) above the
IOM guidelines. As for the relationship between each prepreg-
nancy BMI category and GWG according to the IOM guidelines
(Table 1), approximately 44% of women of underweight had
weight gain below the IOM guidelines. By contrast, more than half
of the overweight or obese women had weight gain in excess of
the IOM guidelines.
Table 2 shows the maternal and pregnancy characteristics
associatedwith GWG relative to IOM guidelines. Women older thanTable 1
Gestational weight gain according to prepregnancy body mass index category.
Weight gain Underweighta (n ¼ 1312) Normal wei
Below IOM guidelines 574 (43.8) 1879 (26.9)
Within IOM guidelines 612 (46.6) 3243 (46.4)
Above IOM guidelines 126 (9.6) 1873 (26.8)
Data presented as n (%).
IOM ¼ Institute of Medicine.
a Underweight, prepregnancy body mass index (BMI) < 18.5 kg/m2.
b Normal weight, prepregnancy BMI ¼ 18.5e24.9 kg/m2.
c Overweight, prepregnancy BMI ¼ 25.0e29.9 kg/m2.
d Obese, prepregnancy BMI 30 kg/m2.
Table 2
Characteristics of the study population with gestational weight gain relative to Institute
Characteristic Below IOM guidelines Wit
Age (y)
<20 6 (0.2)
20e34 1622 (63.0)*** 281
>34 946 (36.8)*** 136
Prepregnancy weight category
Underweight 574 (22.3)*** 61
Normal weight 1879 (73.0)*** 324
Overweight 94 (3.7)*** 28
Obese 27 (1.0) 5
Primiparity 1309 (50.9)*** 233
Prior induced abortion 763 (29.6) 124
Prior fetal death 22 (0.9) 3
Prior preterm birth 9 (0.3) 1
Conception by ART 48 (1.9) 5
Genetic amniocentesis 1029 (40.0)* 156
Smoking during pregnancy 3 (0.1) 1
GBS colonization 379 (14.7) 64
Male fetus 1261 (49.0)* 216
Placenta previa 48 (1.9) 9
Epidural analgesia 1283 (49.8) 212
Induction of labor 385 (15.0)*** 81
Data presented as n (%).
The p values are based on the Chi-square test; *p < 0.05; **p < 0.01; and ***p < 0.001, comp
regression analysis.
ART ¼ artiﬁcial reproductive technology; GBS ¼ group B streptococci.34 years at delivery, of underweight, and having genetic amnio-
centesis were more likely to gain weight below the IOM guidelines.
By contrast, characteristics associated with GWG above the IOM
guidelines included maternal age of 20e34 years, overweight or
obese, primiparity, and having induction of labor.
Table 3 summarizes the association between adverse maternal
outcomes and GWG according to IOM guidelines. Compared to
women with GWG in concordance with the IOM guidelines, the
women who gained less than the IOM guidelines were more likely
to be diagnosed with GDM (adjusted OR 1.5, 95% CI 1.3e1.8) and
had increased risk for placental abruption (adjusted OR 1.7, 95% CI
1.1e2.5). By contrast, women who had GWG above IOM guidelines
were at risk for preeclampsia (adjusted OR 3.0, 95% CI 1.9e4.7) and
primary cesarean delivery (adjusted OR 1.4, 95% CI 1.2e1.6) due to
dysfunctional labor (adjusted OR 1.3, 95% CI 1.1e1.5) and cepha-
lopelvic disproportion (adjusted OR 1.6, 95% CI 1.2e2.2).
The associations between adverse neonatal outcomes and GWG
relative to the IOM guidelines are shown in Table 4. Women with
GWG below the IOM guidelines were more likely to have low birth
weight (adjusted OR 1.9, 95% CI 1.4e2.4) or SGA neonates (adjusted
OR 1.6, 95% CI 1.4e1.9) compared to the women with GWG within
the IOM guidelines. By contrast, the risk for a LGA fetus or macro-
somia increased two fold in the women who gained more than the
IOM guidelines compared to the women who had weight gain
within the IOM guidelines.ghtb (n ¼ 6995) Overweightc (n ¼ 828) Obesed (n ¼ 166)
94 (11.4) 27 (16.3)
280 (33.8) 54 (32.5)
454 (54.8) 85 (51.2)
of Medicine (IOM) guidelines.
hin IOM guidelines Above IOM guidelines p
8 (0.2) 2 (0.1) 0.333
5 (67.2) 1804 (71.1)** <0.001
6 (32.6) 732 (28.8)** <0.001
2 (14.6) 126 (5.0)*** <0.001
3 (77.4) 1873 (73.8)** <0.001
0 (6.7) 454 (17.9)*** <0.001
4 (1.3) 85 (3.3)*** <0.001
8 (55.8) 1573 (62.0)*** <0.001
1 (29.6) 784 (30.9) 0.500
8 (0.9) 23 (0.9) 0.972
3 (0.3) 5 (0.2) 0.546
3 (1.3) 41 (1.6) 0.137
0 (37.2) 892 (35.1) 0.002
0 (0.2) 7 (0.3) 0.386
5 (15.4) 391 (15.4) 0.717
4 (51.7) 1325 (52.2) 0.042
8 (2.3) 51 (2.0) 0.380
8 (52.1) 1326 (52.2) 0.137
8 (19.5) 624 (24.6)*** <0.001
ared to womenwith gestational weight gain within IOM guidelines based on logistic
Table 3
Adverse maternal outcomes associated with gestational weight gain according to the Institute of Medicine (IOM) guidelines.
Outcome Below IOM guidelines
(n ¼ 2574)
Within IOM guidelines
(n ¼ 4189)
Above IOM guidelines
(n ¼ 2538)
Below vs. within Adjusted OR
(95% CI)
Above vs. within
Adjusted OR
(95% CI)
Gestational diabetes mellitus 296 (11.5) 342 (8.2) 195 (7.7) 1.5 (1.3e1.8)a 0.8 (0.6e0.9)a
Preeclampsia 16 (0.6) 31 (0.7) 71 (2.8) 0.9 (0.5e1.7)a 3.0 (1.9e4.7)a
Premature rupture of membranes 8 (0.3) 13 (0.3) 8 (0.3) 1.0 (0.4e2.5)a 0.9 (0.4e2.3)a
Chorioamnionitis 12 (0.5) 37 (0.9) 25 (1.0) 0.6 (0.3e1.2)a 0.9 (0.5e1.5)a
Placental abruption 49 (1.9) 46 (1.1) 24 (0.9) 1.7 (1.1e2.5)a 0.9 (0.6e1.5)a
Placenta accreta 11 (0.4) 16 (0.4) 14 (0.6) 1.0 (0.5e2.2)a 1.7 (0.8e3.5)a
Postpartum hemorrhage 43 (1.7) 76 (1.8) 39 (1.5) 0.9 (0.6e1.4)a 0.8 (0.6e1.3)a
Operative vaginal delivery 67 (2.6) 129 (3.1) 81 (3.2) 0.9 (0.7e1.2)b 1.0 (0.8e1.4)b
Severe perineal injury 155 (6.0) 253 (6.0) 115 (4.5) 1.1 (0.9e1.4)c 0.7 (0.5e0.9)c
Primary cesarean delivery 501 (19.5) 996 (23.8) 809 (31.9) 0.8 (0.7e0.9)d 1.4 (1.2e1.6)d
Dysfunctional labor 157 (6.1) 439 (10.5) 381 (15.0) 0.6 (0.5e0.7)d 1.3 (1.1e1.5)d
Malpresentation 181 (7.0) 283 (6.8) 166 (6.5) 1.0 (0.8e1.3)d 0.9 (0.7e1.1)d
Abnormal FHR pattern 79 (3.1) 137 (3.3) 104 (4.1) 1.0 (0.8e1.3)d 1.1 (0.9e1.5)d
Cephalopelvic disproportion 47 (1.8) 80 (1.9) 100 (3.9) 1.0 (0.7e1.5)d 1.6 (1.2-2.2)d
Data presented as n (%).
CI ¼ conﬁdence interval; FHR ¼ fetal heart rate; OR ¼ odds ratio.
a Adjusted for maternal age at delivery, prepregnancy weight category, parity, prior fetal death, prior preterm birth, conception methods, genetic amniocentesis, smoking
during pregnancy, group B streptococcal colonization at the genitorectal tracts, and fetal sex.
b Adjusted for maternal age at delivery, prepregnancy weight category, parity, prior fetal death, prior preterm birth, conception methods, genetic amniocentesis, smoking
during pregnancy, group B streptococcal colonization at the genitorectal tracts, fetal sex, and intrapartum epidural analgesia.
c Adjusted for maternal age at delivery, prepregnancy weight category, parity, prior fetal death, prior preterm birth, conception methods, genetic amniocentesis, smoking
during pregnancy, group B streptococcal colonization at the genitorectal tracts, fetal sex, intrapartum epidural analgesia, and operative vaginal delivery.
d Adjusted for maternal age at delivery, prepregnancy weight category, parity, prior fetal death, prior preterm birth, conception methods, genetic amniocentesis, smoking
during pregnancy, group B streptococcal colonization at the genitorectal tracts, fetal sex, intrapartum epidural analgesia, and placenta previa.
Table 4
Adverse neonatal outcomes associated with gestational weight gain according to the Institute of Medicine (IOM) guidelines.
Outcome Below IOM guidelines
(n ¼ 2574)
Within IOM guidelines
(n ¼ 4189)
Above IOM guidelines
(n ¼ 2538)
Below vs. within
Adjusted OR (95% CI)a
Above vs. within
Adjusted OR (95% CI)a
Low birth weight 126 (4.9) 107 (2.6) 41 (1.6) 1.9 (1.4e2.4) 0.6 (0.4e0.9)
Small-for-gestational age 278 (10.8) 288 (6.9) 116 (4.6) 1.6 (1.4e1.9) 0.7 (0.5e0.8)
Large-for-gestational age 117 (4.5) 342 (8.2) 356 (14.0) 0.5 (0.4e0.7) 1.8 (1.5e2.1)
Macrosomia 23 (0.9) 63 (1.5) 92 (3.6) 0.6 (0.4e1.0) 2.2 (1.6e3.1)
1-minute AS < 7 18 (0.7) 23 (0.5) 18 (0.7) 1.3 (0.7e2.5) 1.2 (0.7-2.3)
5-minute AS < 7 0 2 (0.0) 2 (0.1) d 1.6 (0.2e11.8)
NICU admission 37 (1.4) 55 (1.3) 30 (1.2) 1.1 (0.7e1.7) 0.9 (0.5e1.4)
Data presented as n (%).
AS ¼ Apgar score; CI ¼ conﬁdence interval; NICU ¼ neonatal intensive care unit; OR ¼ odds ratio.
a Adjusted for maternal age at delivery, prepregnancy weight category, parity, prior induced abortion, prior fetal death, prior preterm birth, conception methods, genetic
amniocentesis, smoking during pregnancy, group B streptococcal colonization at the genitorectal tracts, fetal sex, intrapartum epidural analgesia, and placenta previa.
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Consistent with most prior studies [2e8,10,11], we found sig-
niﬁcant associations between excessive GWG and increased birth
weight (macrosomia) and fetal growth (LGA) and between inade-
quate GWG and decreased birth weight (low birth weight) and fetal
growth (SGA) with respect to the 2009 IOM guidelines. These re-
sults underscore the importance of adherence to the weight gain
recommendations to optimize neonatal outcomes.
Our previous study showed that a high prepregnancy BMI is
associated with the development of preeclampsia [12]. Here, we
further demonstrated that women with GWG above the 2009 IOM
guidelines had a three-fold increased risk for preeclampsia
compared to the womenwho had GWGwithin the guidelines, even
adjusting for the confounding effects of prepregnancy BMI category.
This ﬁnding is consistent with most previous studies regarding
excessive GWG and the risk for preeclampsia [2,3,9e11]. Although
the exact etiology of preeclampsia remains unclear, there is
mounting evidence that preeclampsia can manifest as a result of
generalized maternal endothelial activation, increased inﬂamma-
tory state, and metabolic disorders [13,14]. It is possible that
excessive GWG causes alterations in lipid concentrations andoxidative stress, subsequently leading to increased maternal in-
ﬂammatory response and endothelial activation [15,16]. Indeed, a
recentmeta-analysis found strong evidence that hyperglyceridemia
is associated with and precedes the onset of preeclampsia [17].
Nevertheless, in a review of a total of 13 studies on dietary inter-
vention to prevent excessive weight gain during pregnancy,
Tanentsapf et al [18] found that dietary intervention signiﬁcantly
reduced total GWG, weight retention at 6 months postpartum, and
the risk of cesarean delivery, but had no effect on the incidence of
preeclampsia. Alternatively, the excessive GWG in women with
preeclampsia may be caused by increased ﬂuid retentionwithin the
third space, a feature of preeclampsia that is commonly seen in the
third trimester. Further studies are needed to clarify the causal
relationship between excessive GWG and preeclampsia.
Similar to previous reports [2e4,10,11], we found that women
with GWG above the IOM guidelines were more likely to have ce-
sarean delivery.We further demonstrated that this increased risk of
cesarean delivery was probably related to increased odds for
dysfunctional labor and cephalopelvic disproportion. Both condi-
tions are closely related to increased fetal size (LGA and macro-
somia), which is also more common inwomenwith GWG above the
IOM guidelines.
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recognized risk factor for GDM [19] and several previous studies
have shown that women with excessive GWG are at increased risk
for GDM. However, in this study, we found that women with GWG
below the IOM guidelines had a higher rate of GDM than the
women with GWG within the guidelines. The explanations for this
discrepancy are not clear. It is possible that less total weight gain
during pregnancy in women with GDM was due to the result of
treatment of GDM, including nutritional therapy, modiﬁcation of
life style, regular monitoring of blood sugar levels, and insulin
treatment [20]. Indeed, women who were later diagnosed with
GDM were reported to have greater GWG before undergoing the
screening test at 24 weeks of gestation compared to the women
without GDM [21,22].
Our previous study showed that women with a low prepreg-
nancy BMI were at increased risk for placental abruption [23]. In
the present study, we further demonstrated that womenwith GWG
below the IOM guidelines also had a higher risk for placental
abruption. Similarly, by analyzing more than one million delivery
records, Salihu et al [24] found that women whose GWG was less
than the IOM recommendations had a 67% increased likelihood of
placental abruption, while those who gained more than the rec-
ommended amount of weight had a 30% reduced risk for placental
abruption, compared with the women who gained weight within
the IOM recommendations. Several animal experiments and
observational studies have suggested the potential role of micro-
nutrients such as zinc, b-carotene, and vitamins in pregnancy
complications including placental abruption [25,26]. Together,
these results suggest that maternal nutrition may contribute to the
development of placental abruption.
The strength of this study lies in its ability to include both
nulliparous and multiparous women and to adjust for as many
confounding factors as possible, as well as the use of patient
interview and medical record data rather than relying on vital
statistics or birth certiﬁcate data; thus, the associations between
maternal and neonatal outcomes and GWG with respect to the
2009 IOM guidelines could be objectively investigated.
However, several limitations of our study require attention.
First, the prepregnancy weight was self-reported, which is subject
to recall error and can lead to under- or overestimation of GWG.
Second, this study was limited by its observational and retrospec-
tive design. There might be unmeasured confounders that were not
have accounted for in this study. Third, this study has a limited
sample size of some important but rare pregnancy complications,
such as birth injury and neonatal death. Finally, although we have
examined the associations between excessive or inadequate GWG
and adverse perinatal outcomes, we were not able to conﬁrm the
causal relationship. Further studies including information
regarding the timing of the diagnosis of preeclampsia and GDM
relative to weight gain would help clarify these associations.
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